Janus Henderson Group PLC Purchases 17,641 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Janus Henderson Group PLC increased its position in Addus HomeCare Co. (NASDAQ:ADUSFree Report) by 31.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 73,005 shares of the company’s stock after acquiring an additional 17,641 shares during the period. Janus Henderson Group PLC owned about 0.40% of Addus HomeCare worth $9,150,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently bought and sold shares of the stock. Dimensional Fund Advisors LP lifted its position in shares of Addus HomeCare by 1.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 692,713 shares of the company’s stock valued at $86,833,000 after acquiring an additional 10,434 shares in the last quarter. Capital Research Global Investors purchased a new position in shares of Addus HomeCare in the fourth quarter valued at about $51,149,000. TimesSquare Capital Management LLC lifted its position in shares of Addus HomeCare by 28.5% in the fourth quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company’s stock valued at $44,593,000 after acquiring an additional 78,835 shares in the last quarter. Invesco Ltd. lifted its position in shares of Addus HomeCare by 6.5% in the fourth quarter. Invesco Ltd. now owns 346,120 shares of the company’s stock valued at $43,386,000 after acquiring an additional 21,266 shares in the last quarter. Finally, Northern Trust Corp lifted its position in shares of Addus HomeCare by 3.3% in the fourth quarter. Northern Trust Corp now owns 285,872 shares of the company’s stock valued at $35,834,000 after acquiring an additional 9,122 shares in the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Addus HomeCare Trading Up 1.6%

NASDAQ:ADUS opened at $111.63 on Friday. The company has a market capitalization of $2.05 billion, a P/E ratio of 25.54, a P/E/G ratio of 1.41 and a beta of 0.85. Addus HomeCare Co. has a 12 month low of $88.96 and a 12 month high of $136.72. The business’s 50-day moving average is $100.30 and its 200 day moving average is $113.74.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last issued its quarterly earnings data on Monday, May 5th. The company reported $1.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $337.71 million for the quarter, compared to the consensus estimate of $341.66 million. During the same period in the prior year, the business posted $1.21 earnings per share. The company’s quarterly revenue was up 20.3% compared to the same quarter last year. On average, research analysts forecast that Addus HomeCare Co. will post 4.59 earnings per share for the current year.

Wall Street Analysts Forecast Growth

ADUS has been the topic of several research analyst reports. JMP Securities restated a “market outperform” rating and issued a $150.00 price objective on shares of Addus HomeCare in a research report on Tuesday, April 22nd. Oppenheimer boosted their target price on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Macquarie boosted their target price on Addus HomeCare from $129.00 to $133.00 and gave the stock an “outperform” rating in a research report on Thursday, May 8th. StockNews.com downgraded Addus HomeCare from a “buy” rating to a “hold” rating in a research report on Wednesday, February 26th. Finally, Stephens reiterated an “overweight” rating and issued a $142.00 target price on shares of Addus HomeCare in a research report on Wednesday, March 12th. One research analyst has rated the stock with a hold rating, six have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, Addus HomeCare presently has a consensus rating of “Buy” and an average target price of $142.57.

View Our Latest Stock Analysis on ADUS

Addus HomeCare Company Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Read More

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.